We are live on ! Find out more
RXDX

Prometheus Biosciences, Inc. Common Stock
RXDX

Delisted

RXDX was delisted on the 15th of June, 2023.

Back to rankings

2 hedge funds and large institutions have $1.98M invested in Prometheus Biosciences, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 216 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% less call options, than puts

Call options by funds: $13.6M | Put options by funds: $51.5M

99% less funds holding

Funds holding: 219 → 2 (-217)

100% less capital invested

Capital invested by funds: $4.35B → $1.98M (-$4.35B)

100% less funds holding in top 10

Funds holding in top 10: 13 → 0 (-13)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 216

Holders
2
Holders Change
-217
Holders Change %
-99.09%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-13
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
216
Calls
$13.6M
Puts
$51.5M
Net Calls
-$37.9M
Net Calls Change
-$118M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$351M
2
BlackRock
BlackRock
New York
-$300M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$292M
4
BC
Boxer Capital
California
-$204M
5
7IH
72 Investment Holdings
Connecticut
-$198M
Name Holding Trade Value Shares
Change 		Change in
Stake
SO
151
STRS Ohio
Ohio
– -$719K -6,700 Closed
SACTSONJ
152
Supplemental Annuity Collective Trust (SACT) of New Jersey
New Jersey
– -$644K -6,000 Closed
WMSA
153
Weiss Multi-Strategy Advisers
New York
– -$633K -5,897 Closed
LPL Financial
154
LPL Financial
California
– -$608K -5,667 Closed
MFS
155
Mirabella Financial Services
United Kingdom
– -$1.26M -5,198 Closed
BC
156
BIT Capital
Germany
– -$540K -5,036 Closed
BOH
157
Bank of Hawaii
Hawaii
– -$535K -4,986 Closed
AB
158
Amalgamated Bank
New York
– -$528K -4,917 Closed
Commonwealth Equity Services
159
Commonwealth Equity Services
Massachusetts
– -$431 -4,024 Closed
VF
160
Virtu Financial
New York
– -$424K -3,949 Closed
Connor, Clark & Lunn Investment Management (CC&L)
161
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$411K -3,827 Closed
Zurich Cantonal Bank
162
Zurich Cantonal Bank
Switzerland
– -$407K -3,792 Closed
PNC Financial Services Group
163
PNC Financial Services Group
Pennsylvania
– -$396K -3,691 Closed
AIM
164
Aigen Investment Management
New York
– -$394K -3,672 Closed
AWM
165
Avior Wealth Management
Nebraska
– -$369K -3,434 Closed
EFM
166
E Fund Management
China
– -$362K -3,377 Closed
BAM
167
Blueshift Asset Management
New Jersey
– -$361K -3,363 Closed
MWM
168
Moran Wealth Management
Florida
– -$356K -3,320 Closed
Public Employees Retirement Association of Colorado
169
Public Employees Retirement Association of Colorado
Colorado
– -$351K -3,270 Closed
EGM
170
Engineers Gate Manager
New York
– -$349K -3,255 Closed
HNB
171
Huntington National Bank
Ohio
– -$336K -3,127 Closed
JMPWA
172
JP Morgan Private Wealth Advisors
California
– -$331K -3,081 Closed
Wolverine Trading
173
Wolverine Trading
Illinois
– -$331K -3,075 Closed
Ameriprise
174
Ameriprise
Minnesota
– -$312K -2,910 Closed
MAM
175
Martingale Asset Management
Massachusetts
– -$306K -2,849 Closed
5 6
7
8 9

RXDX Hedge Fund Activity: Q2 2023 in Review

2 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Prometheus Biosciences, Inc. Common Stock (RXDX) for Q2 2023, worth a combined $1.98M — down 100% from $4.35B a quarter earlier.

Sellers outnumbered buyers: 216 funds closed out of RXDX and 0 opened new positions — a net loss of 216 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RTW Investments, exiting entirely with an estimated $351M sold.

  • 2 institutional investors held Prometheus Biosciences, Inc. Common Stock (RXDX) as of Q2 2023, down from 219 in Q1 2023.
  • Funds reported $1.98M of Prometheus Biosciences, Inc. Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Prometheus Biosciences, Inc. Common Stock positions in Q2 2023 and 216 closed out, a net change of -216 holders.
  • The largest Prometheus Biosciences, Inc. Common Stock seller in Q2 2023 was RTW Investments, an estimated $351M sold.

Based on aggregated 13F filings for Q2 2023.